OneMedNet’s Jeffrey Yu buys $250K in common shares

The $250,000 subscription investment used the issuer’s volume-weighted average price for the 10 trading days before the purchase.

Rhea-AI Filing Summary

OneMedNet Corp’s Chief Medical Officer, director and 10% owner Jeffrey Yu purchased 45,126 common shares on October 9, 2026, through a subscription agreement for a $250,000 investment. The shares were valued at $5.54 per share, based on the issuer’s volume-weighted average price for the 10 trading days immediately before the purchase. Yu directly held 896,840 shares after the purchase. Separately, a trust for his children held 131,197 shares with an independent trustee; Yu said he had no investment control and disclaimed beneficial ownership. No Rule 10b5-1 plan is reported.

Insider Trade Summary

Net Buyer: 45,126 shares

Net Buy 2 txns

Insider Yu Jeffrey

Role Chief Medical Officer

Bought 45,126 shs ($250K)

Type	Security	Shares	Price	Value
Purchase	Common Stock F1, F2	45,126	$5.54	$250K
holding	Common Stock F3	--	--	--

Holdings After Transaction: Common Stock — 896,840 shares (Direct); Common Stock — 131,197 shares (Indirect, By trust for children)

Footnotes (3)

1. F1. On October 9, 2026, the issuer entered into a subscription agreement with the reporting person for a $250,000 investment in the issuer.
2. F2. The shares were valued at the volume-weighted average price (VWAP) of the issuer for the 10 trading days immediately prior to the purchase date.
3. F3. The shares are held by trust with an independent trustee, in which the reporting person has no investment control. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 or for any other purpose.

Key Figures

Common shares purchased: 45,126 shares Price per share: $5.54 per share Subscription investment: $250,000 +2 more

5 metrics

Common shares purchased 45,126 shares October 9, 2026

Price per share $5.54 per share Shares valued using the issuer’s volume-weighted average price for the 10 trading days immediately before the purchase

Subscription investment $250,000 Investment in OneMedNet Corp under the subscription agreement

Direct shares held after purchase 896,840 shares Jeffrey Yu’s reported direct holdings after the October 9, 2026 purchase

Shares held by trust for children 131,197 shares Trust with an independent trustee; Yu disclaimed beneficial ownership

Key Terms

volume-weighted average price (VWAP), subscription agreement, beneficial ownership

3 terms

volume-weighted average price (VWAP) financial

"valued at the volume-weighted average price (VWAP)"

Volume-weighted average price (VWAP) is the average price of a security over a trading period where each trade’s price is weighted by how many shares were traded, so larger trades pull the average more than tiny ones. Investors and traders use VWAP as a benchmark to judge whether a trade was executed at a favorable price—similar to checking whether you paid more or less than the typical price when most people were buying or selling.

subscription agreement financial

"issuer entered into a subscription agreement"

A subscription agreement is a legal contract in which an investor agrees to buy a specific number of a company’s shares or other securities under set terms, including price, payment method and conditions for closing the sale. It matters to investors because it legally locks in their purchase and the company’s obligations, determines ownership percentage and any investor rights, and can include conditions or promises that affect future control or returns—like signing a detailed purchase order for equity.

beneficial ownership regulatory

"disclaims beneficial ownership of these shares"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ONMD shares did Chief Medical Officer Jeffrey Yu buy, and at what price?

Jeffrey Yu purchased 45,126 common shares on October 9, 2026, valued at $5.54 per share. The purchase was through a subscription agreement for a $250,000 investment, and the share valuation used the issuer’s volume-weighted average price for the 10 trading days immediately before the purchase. No Rule 10b5-1 plan is reported.

How many ONMD shares were held in trust for Jeffrey Yu’s children?

A trust for Yu’s children held 131,197 common shares. The trust had an independent trustee; Yu had no investment control and disclaimed beneficial ownership of the shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/13/2026 - 08:35 PM EDT Accepted by SEC EDGAR 10/13/2026 - 08:32 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Yu Jeffrey

(Last) (First) (Middle)

6385 OLD SHADY OAK ROAD,

SUITE 250

(Street)

EDEN PRAIRIE MINNESOTA 55344

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
OneMedNet Corp [ ONMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/09/2026		P(1)		45,126	A	$5.54(2)	896,840	D
Common Stock								131,197	I	By trust for children(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On October 9, 2026, the issuer entered into a subscription agreement with the reporting person for a $250,000 investment in the issuer.

2. The shares were valued at the volume-weighted average price (VWAP) of the issuer for the 10 trading days immediately prior to the purchase date.

3. The shares are held by trust with an independent trustee, in which the reporting person has no investment control. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 or for any other purpose.

	/s/ Robert Golden, Attorney-in-Fact	10/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)